News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
209,953 Results
Type
Article (7125)
Company Profile (38)
Press Release (202790)
Section
Business (55575)
Career Advice (174)
Deals (10654)
Drug Delivery (44)
Drug Development (12394)
Employer Resources (35)
FDA (5784)
Job Trends (5365)
News (87005)
Policy (8654)
Tag
2024 BioCapital Digital (1)
2024 BioMidwest Digital (2)
2024 Bio NC Digital (1)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (1)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (1)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
Academia (703)
Adcomms (1)
Allergies (29)
Alliances (15238)
ALS (9)
Alzheimer's disease (316)
Antibody-drug conjugate (ADC) (19)
Approvals (5825)
Artificial intelligence (131)
Autoimmune disease (4)
Automation (3)
Bankruptcy (67)
Best Places to Work (4877)
BIOSECURE Act (4)
Biosimilars (44)
Biotechnology (18)
Bladder cancer (19)
Brain cancer (3)
Breast cancer (77)
Cancer (469)
Cardiovascular disease (47)
Career advice (165)
Career pathing (1)
CAR-T (18)
Cell therapy (75)
Cervical cancer (5)
Clinical research (10481)
Collaboration (246)
Compensation (19)
Complete response letters (2)
COVID-19 (725)
CRISPR (9)
C-suite (74)
Cystic fibrosis (18)
Data (510)
Decentralized trials (1)
Denatured (8)
Depression (11)
Diabetes (74)
Diagnostics (3190)
Digital health (11)
Diversity (3)
Diversity, equity & inclusion (11)
Drug discovery (29)
Drug pricing (45)
Drug shortages (5)
Duchenne muscular dystrophy (25)
Earnings (17745)
Editorial (11)
Employer branding (1)
Employer resources (31)
Events (47871)
Executive appointments (252)
FDA (6165)
Featured Employer (10)
Frontotemporal dementia (3)
Funding (227)
Gene editing (21)
Generative AI (16)
Gene therapy (61)
GLP-1 (160)
Government (1344)
Grass and pollen (2)
Guidances (22)
Healthcare (8598)
Huntington's disease (2)
IgA nephropathy (7)
Immunology and inflammation (16)
Indications (10)
Infectious disease (768)
Inflammatory bowel disease (38)
Inflation Reduction Act (5)
Influenza (11)
Intellectual property (13)
Interviews (15)
IPO (4296)
IRA (16)
Job creations (718)
Job search strategy (155)
Kidney cancer (1)
Labor market (2)
Layoffs (76)
Legal (1654)
Liver cancer (16)
Lung cancer (60)
Lymphoma (33)
Machine learning (1)
Management (14)
Manufacturing (61)
MASH (16)
Medical device (6117)
Medtech (6117)
Mergers & acquisitions (6568)
Metabolic disorders (195)
Multiple sclerosis (26)
NASH (5)
Neurodegenerative disease (14)
Neuropsychiatric disorders (6)
Neuroscience (415)
NextGen: Class of 2025 (2902)
Non-profit (1552)
Northern California (690)
Now hiring (2)
Obesity (110)
Opinion (63)
Ovarian cancer (11)
Pain (17)
Pancreatic cancer (12)
Parkinson's disease (19)
Partnered (7)
Patents (27)
Patient recruitment (26)
Peanut (18)
People (18484)
Pharmaceutical (12)
Pharmacy benefit managers (8)
Phase I (2215)
Phase II (3681)
Phase III (4991)
Pipeline (263)
Podcasts (20)
Policy (39)
Postmarket research (735)
Preclinical (700)
Press Release (10)
Prostate cancer (30)
Psychedelics (5)
Radiopharmaceuticals (76)
Rare diseases (97)
Real estate (1406)
Recruiting (11)
Regulatory (6241)
Reports (16)
Research institute (628)
Resumes & cover letters (13)
Rett syndrome (1)
RSV (15)
Schizophrenia (15)
Series A (35)
Series B (33)
Service/supplier (3)
Sickle cell disease (25)
Southern California (564)
Special edition (6)
Sponsored (6)
Startups (1228)
Stomach cancer (2)
Supply chain (19)
The Weekly (12)
United States (6658)
Vaccines (137)
Venture capitalists (14)
Webinars (4)
Weight loss (58)
Women's health (18)
Worklife (1)
Date
Today (77)
Last 7 days (321)
Last 30 days (1143)
Last 365 days (11974)
2025 (2385)
2024 (11944)
2023 (13078)
2022 (20222)
2021 (21570)
2020 (20922)
2019 (17797)
2018 (13151)
2017 (9000)
2016 (9616)
2015 (11024)
2014 (8138)
2013 (6715)
2012 (7012)
2011 (6972)
2010 (5593)
Location
Africa (231)
Alabama (13)
Alaska (1)
Arizona (62)
Arkansas (5)
Asia (10893)
Australia (1458)
California (1525)
Canada (545)
China (127)
Colorado (104)
Connecticut (73)
Delaware (39)
Europe (26288)
Florida (270)
Georgia (82)
Hawaii (1)
Idaho (19)
Illinois (197)
India (13)
Indiana (123)
Iowa (1)
Japan (63)
Kansas (23)
Kentucky (13)
Louisiana (6)
Maine (26)
Maryland (196)
Massachusetts (1255)
Michigan (81)
Minnesota (120)
Mississippi (2)
Missouri (48)
Montana (5)
Nebraska (13)
Nevada (14)
New Hampshire (24)
New Jersey (554)
New Mexico (7)
New York (517)
North Carolina (369)
North Dakota (1)
Northern California (690)
Ohio (57)
Oklahoma (5)
Oregon (11)
Pennsylvania (438)
Puerto Rico (2)
Rhode Island (6)
South America (308)
South Carolina (6)
Southern California (564)
Tennessee (58)
Texas (206)
Utah (90)
Virginia (35)
Washington D.C. (22)
Washington State (126)
West Virginia (3)
Wisconsin (21)
209,953 Results for "norton healthcare".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Norton Healthcare acquires groundbreaking focused ultrasound technology
October 15, 2024
·
2 min read
Business
Johna Norton to Retire as Lilly Executive Vice President of Global Quality
Eli Lilly and Company announced that Johna Norton, executive vice president of Global Quality, will be retiring after 34 years of service with the company, effective July 31, 2024.
January 25, 2024
·
6 min read
Allogene Therapeutics Activates Three Community Cancer Centers as First Sites for the Pivotal Phase 2 ALPHA3 Trial Evaluating Cemacabtagene Ansegedleucel (cema-cel) as First Line Consolidation Treatment for Patients with Large B-Cell Lymphoma
Allogene Therapeutics Inc. announced that Rocky Mountain Cancer Centers, part of the US Oncology Network and Sarah Cannon Research Institute ; Astera Cancer Care, a multi-specialty community oncology practice and part of the OneOncology network; and Norton Cancer Institute, are open for enrollment in the pivotal Phase 2 ALPHA3 trial.
July 1, 2024
·
10 min read
Press Releases
Werewolf Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Healthcare Conference
November 20, 2024
·
2 min read
Press Releases
Teva to Present at Barclays Global Healthcare Conference and Leerink Partners Global Healthcare Conferences in March
March 3, 2025
·
2 min read
Business
Mountain Valley MD Holdings Appoints Dr. Elizabeth Norton to Advisory Role to Support Key Quicksome™ Vaccine and Cold Chain Projects
Mountain Valley MD Holdings Inc. is pleased to announce the appointment of Dr. Elizabeth Norton to an advisory position to support MVMD’s key Quicksome™ vaccine and cold chain projects.
March 16, 2022
·
5 min read
Drug Development
Healthcare at a Crossroads: Maintaining Good Science in Uncertain Times
Continuing our SCOPE 2025 coverage, Rohit Nambisan, CEO at Lokavant addresses not only current challenges, but the life sciences industry’s responsibility to maintain scientific integrity.
February 17, 2025
·
1 min read
·
Lori Ellis
Press Releases
Altimmune to Participate in the Leerink Global Healthcare Conference
March 4, 2025
·
1 min read
Press Releases
AbbVie to Present at the Leerink Partners Global Healthcare Conference
March 4, 2025
·
1 min read
Press Releases
Neumora Therapeutics to Present at Leerink Global Healthcare Conference
March 4, 2025
·
1 min read
1 of 20,996
Next
